Skip to main content

Table 4 Cost of screening for HCV in the Tromsø 7 Study

From: Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study

 

Cost per analysis

Analyses (n)

Total cost

Cost per newly detected chronic HCV infection (n = 13)

Reagentsa

 

20,946

NOK 922705

(GBP 86,987, € 98,071)

NOK 70977

(GBP 6691, € 7544)

Labour costsb

  

NOK 180000

(GBP 16,969, € 19,132)

NOK 13846

(GBP 1305, € 1472)

Otherc

  

NOK 75000

(GBP 7071, € 7972)

NOK 5769

(GBP 544, € 613)

Total

NOK 56.23

(GBP 5.30, € 5.98)

20,946

NOK 1177705

(GBP 111,028, € 125,175)

NOK 90593

(GBP 8541, € 9629)

  1. Estimated costs for the HCV screening project in Norwegian Kroner (NOK), Pounds (GBP) and Euros (€). 1 GBP and 1 € approximated 10.69 and 9.48 NOK, respectively, as of 2. October 2018. 1 € = 1.15 US Dollars
  2. aReagents (anti-HCV test kits) for this study were provided by Abbvie AS, Norway. Cost is based on prices for test kits used for daily routine HCV testing
  3. bLabour costs in this study were covered by the Northern Norway Regional Health Authorities with the sum mentioned, which was based on estimated time used for testing the samples in the study
  4. cParticipation fee for the Tromsø 7 Study